非瓣膜病性心房颤动的抗栓疗法

[1] Stroke Prevention in Atrial Fibrillation Investigators.Bleeding during antithrombotic therapy in patients with atrial fibrillation. Archives of Internal Medicine . 1996

[2] Atrial Fibrillation Investigators.Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Archives of Internal Medicine . 1994

[3] Bjerkelund CJ,Orning OM.The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. The American Journal of Cardiology . 1969

[4] Laupacis A,Albers G,Dalen J,et al.Antithrombotic therapy in atrial fibrillation.4th ACCP consensus conference on antithrombotic therapy. Chest . 1995

[5] Muramatsu H,Shimura T.Incidence of cerebral thromboembolic infarction associated with paroxysmal and persistent or permanent atrial fibrillation. Journalism Assn of Community College . 2000

[6] Hylek EM,Skates SJ,Sheehan MA,et al.An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. The New England Journal of Medicine . 1996

[7] Wolf PA,Abbott RD,Kennel WB.Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke . 1991

[8] Ezekowitz MD,Levine JA.Preventing stroke in patients with atrial fibrillation. The Journal of The American Medical Association . 1999

[9] EAFT Study Group.European atrial fibrillation trial: secondary prevention of vascular events in patients with nonrheumatic atrial fibrillation and a recent transient ischemic attack or minor ischemic stroke. The Lancet . 1993

[10] Manning WJ,Silverman DI,Keighley CS,et al.Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4. 5-year study. Journalism Assn of Community College . 1995

[1] Stroke Prevention in Atrial Fibrillation Investigators.Bleeding during antithrombotic therapy in patients with atrial fibrillation. Archives of Internal Medicine . 1996

[2] Atrial Fibrillation Investigators.Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Archives of Internal Medicine . 1994

[3] Bjerkelund CJ,Orning OM.The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. The American Journal of Cardiology . 1969

[4] Laupacis A,Albers G,Dalen J,et al.Antithrombotic therapy in atrial fibrillation.4th ACCP consensus conference on antithrombotic therapy. Chest . 1995

[5] Muramatsu H,Shimura T.Incidence of cerebral thromboembolic infarction associated with paroxysmal and persistent or permanent atrial fibrillation. Journalism Assn of Community College . 2000

[6] Hylek EM,Skates SJ,Sheehan MA,et al.An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. The New England Journal of Medicine . 1996

[7] Wolf PA,Abbott RD,Kennel WB.Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke . 1991

[8] Ezekowitz MD,Levine JA.Preventing stroke in patients with atrial fibrillation. The Journal of The American Medical Association . 1999

[9] EAFT Study Group.European atrial fibrillation trial: secondary prevention of vascular events in patients with nonrheumatic atrial fibrillation and a recent transient ischemic attack or minor ischemic stroke. The Lancet . 1993

[10] Manning WJ,Silverman DI,Keighley CS,et al.Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4. 5-year study. Journalism Assn of Community College . 1995